Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/49545
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Synthesis and evaluation of arylquinones as BACE1 inhibitors, b-amyloid peptide aggregation inhibitors, and destabilizers of preformed b-amyloid fibrils |
Autor: | Ortega, Andrea; Rincón, Ángela; Jiménez-Aliaga, Karim L.; Bermejo-Bescós, Paloma; Martín-Aragón, Sagrario; Molina Orden, María Teresa CSIC; Csákÿ, Aurelio G. | Palabras clave: | Alzheimer’s disease BACE1 Ab fibrils Amyloid aggregation Quinones |
Fecha de publicación: | 2011 | Citación: | Bioorganic & Medicinal Chemistry Letters 21 (8) : 2183–2187 (2011) | Resumen: | BACE1 activity, inhibition of Ab aggregation, and disaggregation of preformed Ab fibrils constitute the three major targets in the development of small-molecule lipophilic new drugs for the treatment of Alzheimer’s disease (AD). Quinones are widely distributed among natural products and possess relevant and varied biological activities including antitumor and antibiotic, inhibition of HIV-1 reverse transcriptase, antidiabetic, or COX-inhibition, among others. We report herein the interaction of several arylquinones and their derivatives with the amyloidogenic pathway of the amyloid precursor protein processing. Our studies put forward that these compounds are promising candidates in the development of new drugs which are effective simultaneously towards the three major targets of AD | Versión del editor: | http://dx.doi.org/10.1016/j.bmcl.2011.03.023 | URI: | http://hdl.handle.net/10261/49545 | DOI: | 10.1016/j.bmcl.2011.03.023 |
Aparece en las colecciones: | (IQM) Artículos |
Mostrar el registro completo
CORE Recommender
SCOPUSTM
Citations
32
checked on 08-may-2024
WEB OF SCIENCETM
Citations
33
checked on 29-feb-2024
Page view(s)
299
checked on 09-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.